HepaRegeniX GmbH | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
HepaRegeniX GmbH

BRIEF

published on 10/22/2024 at 10:35, 12 days 2 hours ago

HepaRegeniX Appoints Dr. Martin Bonde as New Chair of the Board

HepaRegeniX HRX-215 Liver Regeneration Martin Bonde Biotech Leadership
BRIEF

published on 10/22/2024 at 10:35, 12 days 2 hours ago

HepaRegeniX nomme le Dr Martin Bonde au poste de nouveau président du conseil d'administration

HepaRegeniX HRX-215 Régénération Du Foie Martin Bonde Leadership En Biotechnologie
PRESS RELEASE

published on 10/22/2024 at 10:30, 12 days 2 hours ago

HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board
HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board, succeeding Elias Papatheodorou who becomes CEO. Preparation for clinical trials ongoing

Clinical Trials HepaRegeniX Liver Regeneration Chair Of The Board Dr. Martin Bonde
BRIEF

published on 07/10/2024 at 09:05, 3 months 24 days ago

HepaRegeniX Raises €15 Million to Advance Liver Regeneration Drug

Clinical Trials HepaRegeniX HRX-215 Liver Regeneration Series C Funding
BRIEF

published on 07/10/2024 at 09:05, 3 months 24 days ago

HepaRegeniX lève 15 millions d'euros pour faire progresser un médicament contre la régénération du foie

Essais Cliniques HepaRegeniX HRX-215 Régénération Du Foie Financement De Série C
PRESS RELEASE

published on 07/10/2024 at 09:00, 3 months 24 days ago

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration
HepaRegeniX raises €15 million Series C round led by Vesalius Biocapital IV to advance clinical development of HRX-215 for liver regeneration, appoints Elias Papatheodorou as CEO and Dr. Linda Greenbaum as CMO

Clinical Development HepaRegeniX HRX-215 Liver Regeneration €15 Million Series C Round
BRIEF

published on 03/14/2024 at 16:20, 7 months 19 days ago

HepaRegeniX Announces Promising Data for Liver Disease Treatment with MKK4 Inhibitor HRX-215

Clinical Study HepaRegeniX HRX-215 Liver Regeneration MKK4 Inhibitor
BRIEF

published on 03/14/2024 at 16:20, 7 months 19 days ago

HepaRegeniX annonce des données prometteuses pour le traitement des maladies du foie avec l'inhibiteur MKK4 HRX-215

Étude Clinique HepaRegeniX HRX-215 Régénération Du Foie Inhibiteur MKK4
PRESS RELEASE

published on 03/14/2024 at 16:15, 7 months 19 days ago

HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
HepaRegeniX publishes data on MKK4 inhibitor HRX-215 for acute and chronic liver diseases in Cell journal, showing safety, liver regeneration, and potential in oncological liver surgery and transplantation

Régénération HepaRegeniX MKK4 Inhibitor Liver Diseases Oncological Surgery

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 23 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 53 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 20 hours 58 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 38 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 19 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE